|description=FDA-approved first-line chemotherapy for unresectable pleural mesothelioma. EMP
...ing:10px; font-weight:bold; width:45%; border-bottom:1px solid #dee2e6;" | FDA approval
...
6 KB (734 words) - 14:18, 21 May 2026
|title=FDA & EPA Talc Asbestos Testing Regulations (2026)
...d EPA regulate asbestos testing in talc: the withdrawn MoCRA testing rule, FDA's own contamination data, and the EU's divergent path.
...
26 KB (3,599 words) - 11:17, 1 June 2026
|title=Mesothelioma Immunotherapy: FDA-Approved Drugs and Effectiveness
...othelioma, pembrolizumab mesothelioma, CheckMate 743, IND227, KEYNOTE-483, FDA approved mesothelioma drugs, checkpoint inhibitor mesothelioma, PD-1 mesoth
...
24 KB (2,899 words) - 23:07, 14 May 2026
...ma timeline, mesothelioma history, asbestos cancer history, CheckMate 743, FDA approval mesothelioma, mesothelioma research milestones
...istopher Wagner's]] 1960 proof that asbestos causes mesothelioma, the 2004 FDA approval of pemetrexed chemotherapy, and [[Dr_Paul_Baas|Dr. Paul Baas's]] [
...
20 KB (2,497 words) - 23:25, 14 May 2026
...thelioma immunotherapy, nivolumab ipilimumab, mesothelioma clinical trial, FDA approval 2020, Dr. Paul Baas, mesothelioma treatment
...font-weight:bold; background:#f8f9fa; border-bottom:1px solid #dee2e6;" | FDA Approval
...
28 KB (3,476 words) - 14:41, 28 May 2026
...P/D)''' over the more aggressive extrapleural pneumonectomy (EPP), and the FDA approved pembrolizumab-based chemoimmunotherapy in September 2024.<ref name
* '''FDA approved chemoimmunotherapy in 2024''' — pembrolizumab plus pemetrexed and
...
23 KB (2,864 words) - 11:39, 31 May 2026
|title=UV1 Telomerase Vaccine (NIPU Trial): Phase 2 Results, FDA Fast Track, Mesothelioma
...TERT vaccine, ipilimumab nivolumab mesothelioma, second-line mesothelioma, FDA Fast Track UV1, pleural mesothelioma vaccine, Haakensen, peptide cancer vac
...
41 KB (5,328 words) - 18:13, 28 May 2026
...han doubled from 8.8 months to 18.1 months. These findings led directly to FDA approval in October 2020, transforming treatment options for mesothelioma p
| style="padding:10px;" | FDA Approval Date
...
28 KB (3,537 words) - 23:25, 14 May 2026
...t established immunotherapy as the new standard of care in 2020.<ref name="fda-nivo-ipi" /> Today, researchers are exploring CAR-T cell therapy, gene ther
...18 months or longer with modern multimodal treatment approaches. The 2020 FDA approval of nivolumab plus ipilimumab marked the first new systemic therapy
...
38 KB (4,762 words) - 23:25, 14 May 2026
...nal and has '''not been approved by the U.S. Food and Drug Administration (FDA)''' for mesothelioma or any other indication.<ref name="ct-evolve" />
* Volrustomig is investigational and not FDA-approved for any indication<ref name="ct-evolve" />
...
22 KB (2,793 words) - 10:05, 31 May 2026
...hensive guide to blood test early detection for mesothelioma including the FDA-approved MESOMARK assay, SOMAmer 13-protein panel, calretinin prediagnostic
| style="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;" | FDA-Approved Test
...
39 KB (5,126 words) - 23:25, 14 May 2026
...r re-review when major medical or legal developments affect their content (FDA approvals, new clinical guidelines, regulatory changes, landmark verdicts,
* New FDA approvals or label changes affecting mesothelioma treatment
...
12 KB (1,591 words) - 17:42, 4 June 2026
...mprehensive guide to blood-based biomarkers for mesothelioma including the FDA-approved MESOMARK assay, fibulin-3, osteopontin, HMGB1, SOMAmer panel, and
| style="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;" | FDA-Approved Test
...
38 KB (4,854 words) - 23:25, 14 May 2026
...c classification 2024, talc cancer evidence, Johnson Johnson talc verdict, FDA talc testing, talc asbestos contamination
...assification system, 67,115 pending lawsuits, $2.5B+ in 2025 verdicts, and FDA regulatory gaps.
...
58 KB (7,890 words) - 05:05, 25 May 2026
...nalyzed in a 1976 study contained tremolite or anthophyllite asbestos, and FDA testing in 2019 still found asbestos in 9 of 52 cosmetic talc samples<ref n
| '''FDA 2019 testing''' || 9 of 52 talc cosmetic samples tested positive for asbest
...
37 KB (4,681 words) - 12:40, 3 June 2026
= Mesothelioma Treatment Options and Costs: 4 FDA-Approved Therapies, 53+ Active Clinical Trials, $100,000-$400,000 Annual Ex
...line nivolumab plus ipilimumab in the CheckMate 743 5-year follow-up. Four FDA-approved treatment pathways exist as of 2026: traditional chemotherapy, imm
...
44 KB (5,390 words) - 10:49, 3 June 2026
...-support tool; not yet standard of care; not Food and Drug Administration (FDA)-cleared as a companion diagnostic; not covered by Medicare or private insu
...e checkpoint inhibitor regimens:''' nivolumab + ipilimumab (CheckMate 743, FDA-approved first-line October 2020) and pembrolizumab + pemetrexed/platinum c
...
36 KB (4,576 words) - 21:55, 25 May 2026
| style="padding:8px 10px; background:#f8f9fa; font-weight:bold;" | FDA-approved serum biomarker
| style="padding:8px 10px;" | SpindleMesoNET AUC 0.989; MesoNet validated; no FDA-cleared mesothelioma-specific tool
...
39 KB (4,780 words) - 23:07, 14 May 2026
|title=Immunotherapy for Mesothelioma: CheckMate 743, Clinical Trials & FDA-Approved Treatment
...ve guide to immunotherapy for malignant pleural mesothelioma including the FDA-approved nivolumab plus ipilimumab combination, CheckMate 743 trial results
...
61 KB (7,899 words) - 23:55, 29 May 2026
...ucts from 1930s hair dryers to modern talc cosmetics. Covers CPSC recalls, FDA testing, J&J litigation, EPA bans, and testing methods.
...ion, asbestos hair dryers, Johnson and Johnson talc, asbestos baby powder, FDA talc testing, CPSC asbestos recall, asbestos popcorn ceiling, asbestos floo
...
65 KB (8,450 words) - 23:24, 14 May 2026
